MegaRobo raises nearly $200 million for AI-driven laboratory systems
The Oman Investment Authority and CMB International joined the funding round as the Chinese company plans expansion across four regions.

Chinese laboratory automation company MegaRobo Technologies said it has secured nearly $200 million from investors including the Oman Investment Authority and CMB International. The company develops systems connecting AI models with robotic equipment to carry out experiments.
The Oman Investment Authority is Oman’s sovereign wealth fund, while CMB International joined as a new investor. Returning backers included Asia Investment Capital, Granite Asia and Sinovation Ventures. MegaRobo did not provide a valuation.
MegaRobo’s technology allows AI to design tests, execute them using laboratory robots and select subsequent experiments based on the findings. The company says its customer base exceeds 500, primarily pharmaceutical manufacturers, biotechnology companies and research laboratories. More than 200 customers have used Megalaxy Lab, its service for submitting experiments to robotic laboratories.
With Tencent Cloud and DNA maker Twist Bioscience, MegaRobo has also launched a protein-design competition called Poreva Open. Megalaxy Lab will conduct physical tests on more than 10,000 proteins designed by AI, with the aim of establishing a shared benchmark grounded in experimental findings.
MegaRobo puts its total funding at about $600 million, including a $300 million Series C supported by Goldman Sachs in 2022. It plans expansion in North America, Europe, the Middle East and Asia, as well as applications for its technology outside science.




